ANDROGENETIC ALOPECIA: FROM MOLECULAR MECHANISMS TO ADVANCED TOPICAL DELIVERY SYSTEMS WITH EMPHASIS ON POLYMERIC MICELLES
International Journal of Drug Delivery Technology · 19.06.2026 · 16 (56s)
DOI: 10.25258/ijddt.16.56s.46 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 19.06.2026. Verfasst von Patel. K und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Androgenetic alopecia (AGA), the most widespread type of non-scarring alopecia, arises from a multistep pathophysiology that includes genetic predisposition, androgen hypersensitivity by dihydrotestosterone through 5α-reductase activity, epigenetic dysregulation including hypomethylation of the Androgen receptor (AR), mitochondrial oxidative stress, perturbation of the telomerase reverse transcriptase (TERT) pathway, and perifollicular fibrosis, leading to miniaturization of the hair follicle with disturbance of anagen-telogen cycling. Conventional therapies with topical minoxidil (5%) and oral finasteride (1 mg) yield poor results, with non-response rates ranging from 40 to 60%, limited follicular penetration, poorer bioavailability for lipophilic agents, and scalp irritation (20-30%) along with systemic side effects like sexual dysfunction (2-5%), thus calling for advanced nanocarriers for targeted delivery. Polymeric micelles, self-assembled from amphiphilic block copolymers (for instance vitamin E TPGS) by employing thin-film hydration or direct dissolution methods, create thermodynamically stable structures in the range of 10 to 100 nm with a hydrophobic core (>80% encapsulation efficiency for minoxidil/finasteride), a hydrophilic PEGylated shell, low critical micelle concentrations (∼0.02 wt%), and inhibition of P-glycoprotein, ensuring superior retention on the scalp, extended release, and targeted delivery for hair follicles against liposomes, solid lipid nanoparticles, or niosomes. This set of micelles can induce the anagen phase, angiogenesis, silencing of AR (e.g., with SAMiRNA), and co-loading multiple drugs method while restricting systemic exposure; thus making polymeric micelles avenues for revolutionary platforms for next-generation AGA combination therapy with improved efficacy, stability, and patient adherence.
Zitieren
APA
K, P., A, P., S, K., & A, S. (2026). ANDROGENETIC ALOPECIA: FROM MOLECULAR MECHANISMS TO ADVANCED TOPICAL DELIVERY SYSTEMS WITH EMPHASIS ON POLYMERIC MICELLES. International Journal of Drug Delivery Technology, 16(56s). https://doi.org/10.25258/ijddt.16.56s.46
Vancouver
K P, A P, S K, A S. ANDROGENETIC ALOPECIA: FROM MOLECULAR MECHANISMS TO ADVANCED TOPICAL DELIVERY SYSTEMS WITH EMPHASIS ON POLYMERIC MICELLES. International Journal of Drug Delivery Technology. 2026;16(56s). doi:10.25258/ijddt.16.56s.46
BibTeX
@article{K2026,
author = {K, Patel. and A, Patil. and S, Kalbag. and A, Salokhe.},
title = {ANDROGENETIC ALOPECIA: FROM MOLECULAR MECHANISMS TO ADVANCED TOPICAL DELIVERY SYSTEMS WITH EMPHASIS ON POLYMERIC MICELLES},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {56s},
doi = {10.25258/ijddt.16.56s.46}
}
EUVIMED